|
Showing 1 - 2 of
2 matches in All Departments
Building on the success of the previous editions, the Textbook of
Drug Design and Discovery, Fifth Edition, has been thoroughly
revised and updated to provide a complete source of information on
all facets of drug design and discovery for students of chemistry,
pharmacy, pharmacology, biochemistry, and medicine. The information
is presented in an up-to-date review form with an underlying and
fundamental focus on the educational aspects. Beginning with an
introduction to drug design and discovery, the first eight chapters
cover molecular recognition, ligand-based drug design, and
biostructure-based drug design. The authors also discuss drug-like
properties and decision making in medicinal chemistry, chemical
biology, natural products in drug discovery, and in vivo imaging in
drug discovery. The middle six chapters provide an overview of
peptide and protein drug design, prodrugs in drug design and
development, and enzyme inhibitors. The authors also go through
receptors (structure, function, and pharmacology), ion channels
(structure and function), and neurotransmitter transporters
(structure, function, and drug binding). The following chapters
address important neurotransmitter systems, GABA and glutamic acid
receptors and transporter ligands, acetylcholine, histamine,
dopamine and serotonin, and opioid and cannabinoid receptors. The
book concludes with an examination of neglected diseases,
anticancer agents, tyrosine kinase receptors, and antibiotics.
Building on the success of the previous editions, the Textbook of
Drug Design and Discovery, Fifth Edition, has been thoroughly
revised and updated to provide a complete source of information on
all facets of drug design and discovery for students of chemistry,
pharmacy, pharmacology, biochemistry, and medicine. The information
is presented in an up-to-date review form with an underlying and
fundamental focus on the educational aspects. Beginning with an
introduction to drug design and discovery, the first eight chapters
cover molecular recognition, ligand-based drug design, and
biostructure-based drug design. The authors also discuss drug-like
properties and decision making in medicinal chemistry, chemical
biology, natural products in drug discovery, and in vivo imaging in
drug discovery. The middle six chapters provide an overview of
peptide and protein drug design, prodrugs in drug design and
development, and enzyme inhibitors. The authors also go through
receptors (structure, function, and pharmacology), ion channels
(structure and function), and neurotransmitter transporters
(structure, function, and drug binding). The following chapters
address important neurotransmitter systems, GABA and glutamic acid
receptors and transporter ligands, acetylcholine, histamine,
dopamine and serotonin, and opioid and cannabinoid receptors. The
book concludes with an examination of neglected diseases,
anticancer agents, tyrosine kinase receptors, and antibiotics.
|
|